Parkinson's, depression, anxiety. Destruction of substantia nigra in the basal ganglia leads to movement disorders, lack of the dopamine in the limbic system leads to emotional disturbances such as depression, anxiety, some roles in schitophrenia, etc.
Dopamine in ecstasy can lead to increased feelings of pleasure, euphoria, and social bonding. This can result in increased risk-taking behavior, heightened impulsivity, and decreased inhibitions. However, prolonged use of ecstasy can deplete dopamine levels, causing mood disturbances and cognitive impairments.
dopamine
decreased levels of luteinizing hormone (LH)
Parkinson's disease is the result of degeneration of dopamine-releasing neurons in the substantia nigra of the brain. This leads to symptoms such as tremors, rigidity, and bradykinesia due to the lack of dopamine, a neurotransmitter involved in controlling movement. Treatment focuses on managing symptoms and may include medications that increase dopamine levels in the brain.
Dopamine is one of several neurotransmitters used in chemical communication between neurons. Dopamine originates in the ventral tegmental area of the midbrain and has wide projections throughout the brain, particularly to the basal ganglia and frontal cortex. Dopamine is a central component in reinforcement-learning as well as reward processing. Parkinson's disease results in depleted dopamine concentration. In contrast, increased dopamine concentration can result in schizophrenic-like behaviors.
Decreased movement of molecules entering the cell
result in decreased breakdown of triglycerides in the bloodstream, leading to increased levels of triglycerides. This could potentially increase the risk of cardiovascular diseases like atherosclerosis and heart disease.
Long-term drug use can lead to damage to dopamine receptors in the brain by overstimulating them, causing them to become less sensitive and reducing the brain's natural production of dopamine. This can result in a decreased ability to experience pleasure and can contribute to addiction and other mental health issues.
Alzheimer's disease is one of the major degenerative disorders of the brain associated with neurotransmitter imbalances, particularly acetylcholine. The other major disorder is Parkinson's disease, which is characterized by a deficiency of dopamine. Both conditions result in significant neurological and cognitive impairments.
Hypoproteinaemia cannot be treated directly as it is usually a result of excessive protein loss (renal disease, gastrointestinal disease for eg), decreased intake (due to malnutrition or intestinal malabsorption) or decreased protein syntheis (liver condition. It can only be treated by treating the exact cause itself. Hypoproteinaemia cannot be treated directly as it is usually a result of excessive protein loss (renal disease, gastrointestinal disease for eg), decreased intake (due to malnutrition or intestinal malabsorption) or decreased protein syntheis (liver condition. It can only be treated by treating the exact cause itself.
Low levels of globulin, specifically hypoalbuminemia, can be caused by a variety of factors including malnutrition, liver disease, kidney disease, gastrointestinal disorders, and certain genetic conditions. Globulins are proteins produced by the liver and immune system, so any disruption in these systems can lead to decreased levels. Further diagnostic testing may be needed to determine the underlying cause of low globulin levels.
Dopamine. which is a neurotrasmitter in the brain.